Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00449-0/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc25&_hsenc=p2ANqtz--2UgIoA6AhUmcnMSZinMUcDojSOc_fPbhi7QQn0ti2BJlRCrqXtKe8ei4EPYtLryRObzV6A_kGSwoZP9zRplOwAvJpxg&_hsmi=354063385&utm_content=354063385&utm_source=hs_email